Orchard Therapeutics competitorsClear all

Orchard Therapeutics's top competitors include Affinia Therapeutics, AID Genomics, Annexon Biosciences and Oxford BioTherapeutics.

Save Comparison	Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.	Affinia Therapeutics Affinia Therapeutics is a biotech company.	AID Genomics AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer.	Annexon Biosciences Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.	Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Founding Date	Founding Date 2015	Founding Date 2019	Founding Date 2013	Founding Date 2011	Founding Date 2004
Type	Type Public	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech genetics healthtech medical diagnostics therapy	Tags Healthcare biotech genetics healthtech therapy	Tags Healthcare biotech genetics medical diagnostics oncology therapy	Tags Healthcare biotech healthtech medical diagnostics therapy	Tags Healthcare biotech drug development genetics healthtech medical diagnostics therapy
Locations	Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US	Locations Waltham, US HQ	Locations Rehovot, IL HQ	Locations South San Francisco, US HQ	Locations Milton, GB HQ San Jose, US
Employees	Employees 252	Employees 532% increase	Employees 398% increase	Employees 558% increase	Employees 284% increase
Alexa Website Rank	Alexa Website Rank 283846	Alexa Website Rank N/A	Alexa Website Rank N/A	Alexa Website Rank 317068	Alexa Website Rank 431847
Financial
Revenue (est.)	Revenue (est.) £1.7m (FY, 2018)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £2.1m (FY, 2018)
Net income	Net income (£184.4m) (FY, 2018)	Net income N/A	Net income N/A	Net income N/A	Net income (£6.5m) (FY, 2018)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 60m (about 1 year ago)	Latest funding round N/A	Latest funding round $ 100m (12 months ago)	Latest funding round $ 10m (almost 6 years ago)
Total funding raised	Total funding raised $ 310.7m	Total funding raised $ 60m	Total funding raised N/A	Total funding raised $ 179m	Total funding raised $ 21.6m